Recent advancements in lung cancer research: a narrative review
This narrative review summarizes recent discoveries and advancements in lung cancer research, highlighting improved diagnostics, targeted and immunotherapies, and insights into the tumor microenvironment.
The article stresses that the substantial progress in diagnostics and therapeutic strategies has the potential to enhance early detection, improve treatment outcomes, and ultimately increase survival rates for lung cancer patients.
Evidence level: Irányelv / elfogadott gyakorlat. Magas szintű klinikai elfogadottság.
Related signals
- Telisotuzumab Vedotin + Osimertinib for Non‑Small Cell Lung Cancer
- Ramucirumab plus erlotinib in patients with untreated, EGFR‑mutated, advanced non‑small‑cell lung cancer (RELAY): a randomised, double‑blind, placebo‑controlled, phase 3 trial
- Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions
- Structured proxy features for multimodal NSCLC survival prediction from pretreatment CT
- Update on the Treatment of Non‑Small Cell Lung Carcinoma (NSCLC)